All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @trtsgtmaj2 on TikTok · 63s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @trtsgtmaj2's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Alright, how often should you be injecting your testosterone?
  2. 0:02This guy right here says, and by the way,
  3. 0:03I'm gonna be a TRT Sergeant Major.
  4. 0:05If you're interested in beginning your online journey,
  5. 0:08TRT, peptides, man, woman, it doesn't matter,
  6. 0:10comment TRT in the comment section or apply directly to you.
  7. 0:14I've been doing TRT for about one and a half to two years,
  8. 0:17one injection every Monday.
  9. 0:19Today I started to have to have the dose,
  10. 0:21and I'll do the other half Thursday,
  11. 0:22just trying something different.
  12. 0:24You think it's worth a try.
  13. 0:25Absa freaking, lutely.
  14. 0:27You always gotta go with what the blood work says, okay?
  15. 0:31But, and it depends, I'm talking about test C,
  16. 0:36sippy and eight, okay?
  17. 0:37There are different types of testosterone out there,
  18. 0:40so we don't get too deep in the rabbit hole over here.
  19. 0:43Testosterone, sippy and eight is what I'm talking about.
  20. 0:46And I think that would be, if that's what you're taking,
  21. 0:48I think that would be worth a try,
  22. 0:49but you definitely are gonna want to consult
  23. 0:52with your doctor on that, okay?
  24. 0:54I do three times a week, I'm on a very low dose,
  25. 0:56because it's not about how much tests we're taking, guys.
  26. 0:58It's about taking the lowest amount and feeling the best,
  27. 1:01but come at Tierra T and I'll see you on the other side.

Can't fact-check @trtsgtmaj2's TRT claims without the video

TrtSgtMaj

TikTok creator

22.1K viewsWatch on TikTok

Quick answer

The creator is describing a switch from once-weekly to twice-weekly testosterone cypionate injections, a protocol adjustment that is pharmacologically sound given the ester's half-life and the peak-to-trough variability associated with single weekly injections. His emphasis on blood work-guided dosing and using the lowest effective dose reflects published clinical guidelines from the Endocrine Society. No specific dose was mentioned, and his recommendation to consult a physician before changing injection frequency is clinically appropriate.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 4 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Can't fact-check @trtsgtmaj2's TRT claims without the video, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Can't fact-check @trtsgtmaj2's TRT claims without the video is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Can't fact-check @trtsgtmaj2's TRT claims without the video" from TrtSgtMaj. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is describing a switch from once-weekly to twice-weekly testosterone cypionate injections, a protocol adjustment that is pharmacologically sound given the ester's half-life and the peak-to-trough variability associated with single weekly injections.

The reason this review is not generic is the source wording and the canonical claim label "trt replying to john sozio." In this clip, the useful excerpt is: "Alright, how often should you be injecting your testosterone?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Twice-weekly split dosing of testosterone cypionate is supported by pharmacokinetic data and is a standard clinical adjustment, not an experimental approach.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is describing a switch from once-weekly to twice-weekly testosterone cypionate injections, a protocol adjustment that is pharmacologically sound given the ester's half-life and the peak-to-trough variability associated with single weekly injections.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is describing a switch from once-weekly to twice-weekly testosterone cypionate injections, a protocol adjustment that is pharmacologically sound given the ester's half-life and the peak-to-trough variability associated with single weekly injections. His emphasis on blood work-guided dosing and using the lowest effective dose reflects published clinical guidelines from the Endocrine Society. No specific dose was mentioned, and his recommendation to consult a physician before changing injection frequency is clinically appropriate.
  • Testosterone cypionate has a half-life of approximately 8 days (Bhasin et al., 2010, JCEM), but once-weekly injections can still produce significant peak-to-trough swings in serum levels that affect mood, energy, and estradiol.
  • Twice-weekly split dosing of testosterone cypionate is supported by pharmacokinetic data and is a standard clinical adjustment, not an experimental approach.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone cypionate has a half-life of approximately 8 days (Bhasin et al., 2010, JCEM), but once-weekly injections can still produce significant peak-to-trough swings in serum levels that affect mood, energy, and estradiol.
  • Twice-weekly split dosing of testosterone cypionate is supported by pharmacokinetic data and is a standard clinical adjustment, not an experimental approach.
  • The Endocrine Society's 2018 TRT guideline recommends titrating to mid-normal physiological testosterone levels, not the highest tolerated dose, which supports the creator's 'lowest effective dose' framing.
  • Changing injection frequency without corresponding blood work adjustments is a common patient error. Labs must be drawn at a consistent time post-injection to produce comparable data across visits.
  • Erythrocytosis and elevated estradiol are the two most common monitored risks on TRT protocols. More frequent dosing can affect both, so provider oversight after a protocol change is not optional.
  • The Monday/Thursday twice-weekly schedule the creator describes is a recognized clinical protocol for testosterone cypionate and matches guidance from multiple men's health specialty organizations.
  • Viewers should be aware this content comes from a creator who is also promoting a telehealth service. The underlying advice is sound, but the commercial context is worth factoring into how you receive it.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @trtsgtmaj2 actually say?

The creator, who frames himself as a TRT guide, described switching from a single weekly injection of testosterone cypionate to splitting that same dose across two injections per week, Monday and Thursday. He said he's been on TRT for "one and a half to two years" and is now trying something different. His core position: splitting the dose is "worth a try," blood work should drive decisions, and "it's not about how much test you're taking" but about the lowest effective dose. He also recommended viewers consult their doctor before making changes.

He was specifically talking about testosterone cypionate, and he flagged that other testosterone esters exist, so the advice doesn't universally apply. That caveat deserves credit. The promotional framing, pushing viewers to comment "TRT" to start their own online treatment journey, is worth flagging as context for who's giving this advice.

Does the science back this up?

Yes, for the most part. The pharmacokinetics of testosterone cypionate support split dosing, and this is actually what many endocrinologists now prefer in practice. A single weekly injection of test cypionate creates a significant peak-to-trough swing in serum testosterone levels that can contribute to mood instability, energy crashes, and erratic estradiol conversion.

Testosterone cypionate has a half-life of approximately 8 days (Bhasin et al., 2010, Journal of Clinical Endocrinology and Metabolism), which might suggest once-weekly dosing is fine. But in practice, supraphysiologic peaks early in the week followed by sub-therapeutic troughs before the next injection are a documented clinical problem. Dividing doses reduces that variability. A 2018 analysis in Translational Andrology and Urology (Ramasamy et al.) noted that more frequent, smaller injections generally produce more stable serum testosterone and estradiol levels, with patients often reporting improved symptom consistency. The creator's instinct here matches established pharmacology, even if he didn't cite the mechanism.

What did they get wrong (or right)?

He got the practical recommendation right. Split dosing testosterone cypionate is not fringe advice, it is increasingly standard practice among urologists and men's health specialists managing TRT. The Monday/Thursday schedule he describes is a textbook split for a twice-weekly protocol.

He also got the philosophy right. "It's not about how much test you're taking" reflects the clinical principle of using the minimum effective dose, which reduces the risk of erythrocytosis, elevated hematocrit, and excessive estradiol conversion. The Endocrine Society's 2018 clinical practice guideline explicitly recommends titrating to the mid-normal physiological range rather than maximizing levels.

What he got murkier: he didn't distinguish between adjusting injection frequency (same total dose, split differently) and adjusting total weekly dose. Those are different interventions with different implications. If someone hears "split your dose" and misunderstands it as "take more injections plus the same amount each time," that's a meaningful error in practice. The creator didn't clarify this explicitly enough.

What should you actually know?

If you're on testosterone cypionate and experiencing energy crashes mid-week, mood dips, or inconsistent symptoms, split dosing is a legitimate option to raise with your prescribing provider. This is not experimental. It is a standard adjustment that many clinicians make when patients report peak-and-trough symptoms on once-weekly protocols.

However, changing your injection frequency, even with the same total weekly dose, can affect your estradiol levels, hematocrit, and how your lab work reads. Blood work timing relative to your last injection matters enormously for interpreting results. The Endocrine Society and American Urological Association both recommend monitoring labs at consistent intervals post-injection to get comparable data across visits.

One thing the creator is correct about: blood work drives these decisions. Self-adjusting TRT protocols without corresponding lab monitoring is how people end up with symptomatic estradiol problems or polycythemia they don't catch early. If you want to try split dosing, talk to your provider, get baseline labs, and recheck after 6 to 8 weeks on the new protocol.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

TrtSgtMaj · TikTok creator

22.1K views on this video

Replying to @John Sozio

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about testosterone cypionate has a half-life of approximately 8 days (bhasin?

Testosterone cypionate has a half-life of approximately 8 days (Bhasin et al., 2010, JCEM), but once-weekly injections can still produce significant peak-to-trough swings in serum levels that affect mood, energy, and estradiol.

What does the video say about twice-weekly split dosing of testosterone cypionate?

Twice-weekly split dosing of testosterone cypionate is supported by pharmacokinetic data and is a standard clinical adjustment, not an experimental approach.

What does the video say about the endocrine society's 2018 trt guideline recommends titrating to mid-normal?

The Endocrine Society's 2018 TRT guideline recommends titrating to mid-normal physiological testosterone levels, not the highest tolerated dose, which supports the creator's 'lowest effective dose' framing.

What does the video say about changing injection frequency without corresponding blood work adjustments?

Changing injection frequency without corresponding blood work adjustments is a common patient error. Labs must be drawn at a consistent time post-injection to produce comparable data across visits.

What does the video say about erythrocytosis?

Erythrocytosis and elevated estradiol are the two most common monitored risks on TRT protocols. More frequent dosing can affect both, so provider oversight after a protocol change is not optional.

What does the video say about the monday/thursday twice-weekly schedule the creator describes?

The Monday/Thursday twice-weekly schedule the creator describes is a recognized clinical protocol for testosterone cypionate and matches guidance from multiple men's health specialty organizations.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by TrtSgtMaj, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.